Evidence map›Paper›PMID 32430881›Full record

ArticleInternational journal of clinical pharmacy2021

Patient safety incidents involving transdermal opioids: data from the Danish Patient Safety Database.

A E Olesen, J N Henriksen, L P Nielsen, P Knudsen, B K Poulsen

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Overview of this issue: "Pain management in an opioid crisis".International journal of clinical pharmacy · 2021
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

A E OlesenDepartment of Clinical Pharmacology, Aalborg University Hospital, Gartnerboligen, ground floor Mølleparkvej 8a, 9000, Aalborg, Denmark. aneso@rn.dk.ORCID http://orcid.org/0000-0001-9365-1918
J N HenriksenDepartment of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark.
L P NielsenDepartment of Clinical Pharmacology, Aalborg University Hospital, Gartnerboligen, ground floor Mølleparkvej 8a, 9000, Aalborg, Denmark.
P KnudsenDivision of Knowledge and Learning, The Danish Patient Safety Authority, Copenhagen, Denmark.
B K PoulsenDepartment of Clinical Pharmacology, Aalborg University Hospital, Gartnerboligen, ground floor Mølleparkvej 8a, 9000, Aalborg, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Transdermal opioids are widely used among elderly adults with chronic pain. However, transdermal patches may be involved in a significant proportion of opioid-related patient safety incidents, as the application process includes several subprocesses, each associated with an individual risk of error. Objective The aim was to obtain specific knowledge on patient safety incidents related to transdermal opioid treatment within both the primary care sector and the hospital sector in Denmark. Setting The study is descriptive with data provided by the Danish Patient Safety Database. Methods We manually retrieved all patient safety incidents concerning transdermal opioids reported for 2018 from (1) the hospital sector and (2) the primary care sector. Study data were collected and managed using REDCap electronic data capture tools. Main outcome measure The available information for each incident was sorted into the following categories: location, medication process, type of problem, outcome at time of reporting, and outcome classification. Results A total of 866 patient safety incidents involving transdermal opioids were reported to the Danish Patient Safety Database in 2018. No fatal incidents were present in the database. In 386 cases, the incidents were reported as harmful, and these 386 cases were analysed. Most reports came from the primary care sector (nursing home, home care or social housing). The majority of incidents were related to the administration of the patch in the medication process, and the most prevalent problem was the omission of doses. Conclusion This study has demonstrated that the administration of transdermal opioids is challenging and may cause harm, particularly in the primary care sector. To improve patient safety, optimized systems, including guidelines on drug management and the continuing education of healthcare personnel in transdermal opioid management, are necessary. These guidelines should preferably incorporate reminders and checklists, since the omission of doses was the most reported problem.

Indexed as

Analgesics, OpioidPatient SafetyAdultAgedDatabases, FactualDenmarkHospitalsHumansAnalgesics, OpioidIncidentsMedication errorOpioidsSafetyTransdermal application

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.